July 30, 2021 - ROSEN LOGO.jpg
RAD LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – RAD
22 avr. 2023 20h32 HE | The Rosen Law Firm PA
NEW YORK, April 22, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018...
Global Neuropathic Ocular Pain Market
Global Neuropathic Ocular Pain Market Report 2023: Increase in Product Launches by Key Market Players Drives Growth
18 avr. 2023 10h28 HE | Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Neuropathic Ocular Pain Market, By Drug Class, By Distribution Channel, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030"...
22157.jpg
U.S. Opioid Induced Constipation Market Report 2023: Presence of Diversified Treatments for Opioid-Induced Constipation Bolsters Growth
14 avr. 2023 06h58 HE | Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Opioid Induced Constipation Market Research Report by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - United States...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RAD
31 mars 2023 12h23 HE | The Rosen Law Firm PA
NEW YORK, March 31, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 26, 2018...
Experts to Explore S
Experts to Explore Safe Prescribing and Alternatives to Opioids in Upcoming Webinar
27 mars 2023 10h22 HE | Partnership for a Drug-Free New Jersey
Millburn, New Jersey, March 27, 2023 (GLOBE NEWSWIRE) -- National experts on opioid safety and prescribing will highlight effective alternatives to opioids and recent updates to prescribing...
Global Paracetamol IV Market
Global Paracetamol IV Market Research Report to 2030 - Enhanced Usage of Acetaminophen to Reduce the Dependence on Opioids for Pain Management Drives Growth
23 févr. 2023 11h33 HE | Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Paracetamol IV Market Research Report by Indication (Pain and Pyrexia/Fever), Application, End-use, Region - Cumulative Impact of COVID-19, Russia...
Webinar to Provide P
Webinar to Provide Parents Key Information on Opioids
20 févr. 2023 09h00 HE | Partnership for a Drug-Free New Jersey
Millburn, New Jersey, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Parents play a crucial role in preventing their children from using or misusing opioids, but they are not always fully informed about the...
Analgesics Market GNW_11zon.jpg
Analgesics Market to Reach USD 56.86 Million by 2030, States a New Report by Next Move Strategy Consulting
09 févr. 2023 09h00 HE | Next Move Strategy Consulting
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the Global Analgesics Market is estimated to be USD 35.03 million in 2021 and is...
Medical Cannabis Market
Medical Cannabis Global Market Report 2023: Sector to Reach $57.4 Billion by 2028 at a CAGR of 10.34%
09 févr. 2023 07h53 HE | Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
PDFNJ 2023 Public Service Campaigns
The Partnership for a Drug-Free New Jersey Warns Parents about the Dangers of Opioid Prescribing for Wisdom Tooth Removal in New PSA Campaig
31 janv. 2023 14h30 HE | Partnership for a Drug-Free New Jersey
Washington, D.C., Jan. 31, 2023 (GLOBE NEWSWIRE) --  The Partnership for a Drug-Free New Jersey (PDFNJ) 2023 public service campaign is putting the focus on key issues facing New Jersey families—...